BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 25399704)

  • 1. Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine-seeking behaviour in rats.
    Baracz SJ; Everett NA; McGregor IS; Cornish JL
    Addict Biol; 2016 Mar; 21(2):316-25. PubMed ID: 25399704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Involvement of Oxytocin in the Subthalamic Nucleus on Relapse to Methamphetamine-Seeking Behaviour.
    Baracz SJ; Everett NA; Cornish JL
    PLoS One; 2015; 10(8):e0136132. PubMed ID: 26284529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core.
    Everett N; Baracz S; Cornish J
    Pharmacol Biochem Behav; 2019 Aug; 183():64-71. PubMed ID: 31202809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement.
    Everett NA; McGregor IS; Baracz SJ; Cornish JL
    Neuropharmacology; 2018 May; 133():1-11. PubMed ID: 29353054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic Methamphetamine Self-Administration Dysregulates Oxytocin Plasma Levels and Oxytocin Receptor Fibre Density in the Nucleus Accumbens Core and Subthalamic Nucleus of the Rat.
    Baracz SJ; Parker LM; Suraev AS; Everett NA; Goodchild AK; McGregor IS; Cornish JL
    J Neuroendocrinol; 2016 Apr; 28(4):. PubMed ID: 26563756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adolescent pre-treatment with oxytocin protects against adult methamphetamine-seeking behavior in female rats.
    Hicks C; Cornish JL; Baracz SJ; Suraev A; McGregor IS
    Addict Biol; 2016 Mar; 21(2):304-15. PubMed ID: 25402719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin Acts in Nucleus Accumbens to Attenuate Methamphetamine Seeking and Demand.
    Cox BM; Bentzley BS; Regen-Tuero H; See RE; Reichel CM; Aston-Jones G
    Biol Psychiatry; 2017 Jun; 81(11):949-958. PubMed ID: 28110822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicotine- and cocaine-triggered methamphetamine reinstatement in female and male Sprague-Dawley rats.
    Pittenger ST; Chou S; Barrett ST; Catalano I; Lydiatt M; Bevins RA
    Pharmacol Biochem Behav; 2017 Aug; 159():69-75. PubMed ID: 28712749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of mGlu2/3 receptors in the nucleus accumbens prevents oxytocin from reducing cued methamphetamine seeking in male and female rats.
    Bernheim A; Leong KC; Berini C; Reichel CM
    Pharmacol Biochem Behav; 2017 Oct; 161():13-21. PubMed ID: 28870523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of activated glial condition medium in the nucleus accumbens extended extinction and intensified reinstatement of methamphetamine-induced conditioned place preference.
    Arezoomandan R; Moradi M; Attarzadeh-Yazdi G; Tomaz C; Haghparast A
    Brain Res Bull; 2016 Jul; 125():106-16. PubMed ID: 27346277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats.
    Parsegian A; See RE
    Neuropsychopharmacology; 2014 Mar; 39(4):811-22. PubMed ID: 23995583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment.
    Everett NA; Carey HA; Cornish JL; Baracz SJ
    J Psychopharmacol; 2020 Nov; 34(11):1271-1279. PubMed ID: 33081558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats.
    Pittenger ST; Barrett ST; Chou S; Bevins RA
    Behav Brain Res; 2017 Mar; 320():195-199. PubMed ID: 27939341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social stress-potentiated methamphetamine seeking.
    Blouin AM; Pisupati S; Hoffer CG; Hafenbreidel M; Jamieson SE; Rumbaugh G; Miller CA
    Addict Biol; 2019 Sep; 24(5):958-968. PubMed ID: 30105771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of oxytocin on methamphetamine-seeking exacerbated by predator odor pre-exposure in rats.
    Ferland CL; Reichel CM; McGinty JF
    Psychopharmacology (Berl); 2016 Mar; 233(6):1015-24. PubMed ID: 26700240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of the D2 dopamine receptor antagonist sulpiride into the shell, but not the core, of the nucleus accumbens attenuates cocaine priming-induced reinstatement of drug seeking.
    Anderson SM; Schmidt HD; Pierce RC
    Neuropsychopharmacology; 2006 Jul; 31(7):1452-61. PubMed ID: 16205775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline, an antibiotic with inhibitory effect on microglial activation, attenuates the maintenance and reinstatement of methamphetamine-seeking behavior in rat.
    Attarzadeh-Yazdi G; Arezoomandan R; Haghparast A
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():142-8. PubMed ID: 24768984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.
    Pittenger ST; Barrett ST; Chou S; Bevins RA
    Behav Brain Res; 2016 Mar; 300():150-9. PubMed ID: 26638833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference.
    Baracz SJ; Rourke PI; Pardey MC; Hunt GE; McGregor IS; Cornish JL
    Behav Brain Res; 2012 Mar; 228(1):185-93. PubMed ID: 22155611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of methamphetamine seeking by the mGluR2/3 agonist LY379268 in rats with histories of restricted and escalated self-administration.
    Kufahl PR; Watterson LR; Nemirovsky NE; Hood LE; Villa A; Halstengard C; Zautra N; Olive MF
    Neuropharmacology; 2013 Mar; 66():290-301. PubMed ID: 22659409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.